SCHEMBL22817736

SCHEMBL22817736

c1ccc(-c2ccc(-c3cc4c(oc5cccc(N(c6ccc(-c7cccc8c7oc7ccccc78)cc6)c6ccccc6-c6ccccc6)c54)c4ccccc34)cc2)cc1

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ALOX5 P09917 2/20 0.45
▸ GGPS1 O95749 1/20 0.38
▸ PRKDC P78527 8/20 0.35
▸ PTGES2 Q9H7Z7 1/20 0.35
▸ CDC14B O60729 2/20 0.34
▸ CDC14A Q9UNH5 2/20 0.34
▸ PRMT5 O14744 1/20 0.32
▸ WDR77 Q9BQA1 1/20 0.32
▸ ATM Q13315 1/20 0.31
▸ ALDH1A1 P00352 3/20 0.31
▸ PIK3CD O00329 2/20 0.31
▸ PIK3CA P42336 2/20 0.31
▸ PIK3CB P42338 2/20 0.31
▸ PIK3CG P48736 2/20 0.31
▸ CYP1A2 P05177 2/20 0.31
▸ KDM4E B2RXH2 2/20 0.31
▸ BRD4 O60885 2/20 0.31
▸ BRD2 P25440 2/20 0.31
▸ BRD3 Q15059 2/20 0.31
▸ SMN1; SMN2 Q16637 2/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22818259 0.99 ALOX5 (0.46) ALOX5GGPS1PRKDCPTGES2CDC14B
SCHEMBL22817743 0.97 ALOX5 (0.46) ALOX5GGPS1PRKDCPTGES2CDC14B
SCHEMBL22817872 0.95 ALOX5 (0.47) ALOX5GGPS1PRKDCPTGES2CDC14B
SCHEMBL26486058 0.95 ALOX5 (0.47) ALOX5GGPS1PRKDCPTGES2CDC14B
SCHEMBL22818193 0.95 ALOX5 (0.47) ALOX5GGPS1PRKDCPTGES2CDC14B
SCHEMBL22817960 0.95 ALOX5 (0.38) ALOX5GGPS1PRKDCCDC14BCDC14A
SCHEMBL22817658 0.95 ALOX5 (0.38) ALOX5GGPS1PRKDCCDC14BCDC14A
SCHEMBL22818196 0.95 ALOX5 (0.38) ALOX5GGPS1PRKDCCDC14BCDC14A
SCHEMBL22817931 0.95 ALOX5 (0.38) ALOX5GGPS1PRKDCCDC14BCDC14A
SCHEMBL22817685 0.95 ALOX5 (0.38) ALOX5GGPS1PRKDCCDC14BCDC14A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11812623-B2 Hetero-cyclic compound and organic light emitting device using the same LT MATERIALS CO., LTD. (KR) 2023-11-07 — — US disclosed
US-11812623-B2 Hetero-cyclic compound and organic light emitting device using the same LT MATERIALS CO., LTD. (KR) 2023-11-07 — — US disclosed
US-20200403157-A1 HETERO-CYCLIC COMPOUND AND ORGANIC LIGHT EMITTING DEVICE USING THE SAME LT MATERIALS CO., LTD. (KR) 2020-12-24 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11812623-B2 Hetero-cyclic compound and organic light emitting device using the same CRY1, CRY2, PER2 ALOX5 1385/4885GGPS1 598/4885PRKDC 2919/4885
US-20200403157-A1 HETERO-CYCLIC COMPOUND AND ORGANIC LIGHT EMITTING DEVICE USING THE SAME CRY1, CRY2, PER2 ALOX5 1385/4885GGPS1 598/4885PRKDC 2919/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback